Post-Herpetic Neuralgia Treatment Market Projected to Reach $1.38 Billion by 2034, Growing at a CAGR of 5.3% | Fact.MR Report
November 04, 2024 07:30 ET
|
FACT.MR
Rockville, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global post herpetic neuralgia treatment market is calculated to reach a size of US$ 822.4 million in 2024 and climb to US$ 1.38 billion by the...
MADD Canada Holds Memorial Ceremony to Honour Victims of Impaired Driving
October 03, 2024 05:30 ET
|
MADD Canada
GRAND FALLS-WINDSOR, Newfoundland and Labrador, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Families and friends of innocent victims of alcohol and drug-related crashes will gather this Saturday to honour...
Names of Four Nova Scotia Victims of Impaired Driving will be Added to the Provincial Monument
September 11, 2024 07:00 ET
|
MADD Canada
DARTMOUTH, Nova Scotia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- MADD Canada will hold its annual Memorial Ceremony to pay tribute to those who lost their lives or suffered injuries in crashes involving...
Avid Bioservices to Participate at Upcoming Investor Conferences
May 07, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
[Latest] Global Cancer Supportive Care Drugs Market Size/Share Worth USD 32,783.2 Billion by 2033 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 06, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Supportive Care Drugs Market Size, Trends and Insights By Drug Type...
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
April 24, 2024 17:25 ET
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion...
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
February 28, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and BUNNIK, the Netherlands, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
February 01, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Contraceptives Market revenue to exceed USD 45 Billion by 2033, says Research Nester
January 24, 2024 06:30 ET
|
Research Nester
New York , Jan. 24, 2024 (GLOBE NEWSWIRE) -- The global contraceptives market size is projected to grow at a CAGR of over 6% from 2023 to 2033. The market is expected to garner a revenue of USD 45...
Peripheral Neuropathy Market Size Worth USD 8.54 Billion in 2032 | Emergen Research
January 22, 2024 10:57 ET
|
Emergen Research
Vancouver, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global peripheral neuropathy market size was USD 3.61 Billion in 2022 and is expected to register a revenue CAGR of 9.0% during the forecast period....